Calithera

First-quarter catalysts for the smaller players
EP Vantage
Fri, 12/18/20 - 10:54 am
FDA
Supernus
Wave Life Sciences
Rhythm
Calithera
Matinas
Regenexbio
Incyte grabs control of a cancer drug from Calithera’s pipeline for $53M up front
Endpoints
Mon, 01/30/17 - 10:19 am
Inctye
Calithera
CB-1158
immuno-oncology
19 Lesser-Known Biotech Stocks With Robust Drug Pipelines
Yahoo/Benzinga
Wed, 12/31/14 - 10:37 am
biotech
Threshold Pharmaceuticals
Acceleron
Spectrum Pharmaceuticals
Ultragenyx
Argos Therapeutics
OncoMed
Peregrine Pharmaceuticals
Incyte
Calithera
Array Biopharma
Theravance
Puma Biotechnology
CTI BioPharma
Orexigen
Enanta Pharmaceuticals
Sucampo
Exelixis
Cubist Pharmaceuticals
United Therapeutics
Biotech Company Calithera Wakes Up Sleepy IPO Market
Silicon Beat
Mon, 08/25/14 - 10:21 pm
IPOs
Calithera
cancer